Esperion Therapeutics Inc (ESPR) to Post FY2015 Earnings of ($2.36)...
Esperion Therapeutics Inc - Lake Street Capital decreased their FY2015 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Thursday, according to Zacks Investment Research . Lake Street Capital analyst C. Byrnes now forecasts that the brokerage will earn per share for the year, down from their prior forecast of .
from Biotech News
0 Comments